Stocks closed higher on Wall Street at the start of a holiday-shortened week.
The S&P 500 rose 0.7% Monday. Several big technology companies helped support the gains, including chip companies Nvidia and Broadcom. The Dow Jones Industrial Average added 0.2%, and the Nasdaq composite rose 1%.
Honda’s U.S.-listed shares rose sharply after the company said it was in talks about a combination with Nissan in a deal that could also include Mitsubishi Motors. Eli Lilly rose after announcing that regulators approved Zepbound as the first prescription medicine for adults with sleep apnea. Treasury yields rose in the bond market.
On Monday:
The S&P 500 rose 43.22 points, or 0.7%, to 5,974.07.
The Dow Jones Industrial Average rose 66.69 points, or 0.2%, to 42,906.95.
The Nasdaq composite rose 192.29 points, or 1%, to 19,764.89.
The Russell 2000 index of smaller companies fell 4.93 points, or 0.2%, to 2,237.44.
For the year:
The S&P 500 is up 1,204.24 points, or 25.2%.
The Dow is up 5,217.41 points, or 13.8%.
The Nasdaq is up 4,753.53 points, or 31.7%.
The Russell 2000 is up 210.36 points, or 10.4%.
Before you consider Eli Lilly and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.
While Eli Lilly and Company currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
